NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
S-3	May 5, 2023	FORM S-3
8-K	Mar 31, 2023	FORM 8-K
10-Q	Feb 14, 2023	10-Q
8-K	Feb 13, 2023	FORM 8-K
DEFA14A	Dec 23, 2022	DEFA14A
8-K	Dec 22, 2022	FORM 8-K
DEF 14A	Nov 15, 2022	DEF 14A
10-Q	Nov 14, 2022	10-Q
PRE 14A	Nov 4, 2022	PRE 14A
10-K	Oct 13, 2022	10-K
8-K	Oct 11, 2022	FORM 8-K
NT 10-K	Sep 29, 2022	NT 10-K
4	Aug 10, 2022	FORM 4
10-Q	May 16, 2022	10-Q
10-Q	Feb 14, 2022	10-Q
8-K	Nov 26, 2021	FORM 8-K
10-Q	Nov 15, 2021	FORM 10-Q
10-K	Oct 12, 2021	FORM 10-K
DEF 14A	Oct 12, 2021	DEF 14A
NT 10-K	Sep 28, 2021	NT 10-K
8-K	Sep 21, 2021	FORM 8-K
8-K	Sep 15, 2021	FORM 8-K
10-Q	May 14, 2021	FORM 10-Q
10-Q	Feb 16, 2021	FORM 10-Q
SC 13G/A	Feb 16, 2021	SC 13G/A

← Newer Page 4 of 23 · 556 filings Older →